Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity

Cytochrome P450 3A (CYP3A) subfamily enzymes are involved in the metabolism of 40% of drugs in clinical use. Twin studies have indicated that 66% of the variability in CYP3A4 activity is hereditary. Yet, the complexity of the CYP3A locus and the lack of distinct drug metabolizer phenotypes has limit...

Full description

Bibliographic Details
Main Authors: Qinglian Zhai, Maaike van der Lee, Teun van Gelder, Jesse J. Swen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.912618/full
_version_ 1818231647019991040
author Qinglian Zhai
Maaike van der Lee
Teun van Gelder
Jesse J. Swen
author_facet Qinglian Zhai
Maaike van der Lee
Teun van Gelder
Jesse J. Swen
author_sort Qinglian Zhai
collection DOAJ
description Cytochrome P450 3A (CYP3A) subfamily enzymes are involved in the metabolism of 40% of drugs in clinical use. Twin studies have indicated that 66% of the variability in CYP3A4 activity is hereditary. Yet, the complexity of the CYP3A locus and the lack of distinct drug metabolizer phenotypes has limited the identification and clinical application of CYP3A genetic variants compared to other Cytochrome P450 enzymes. In recent years evidence has emerged indicating that a substantial part of the missing heritability is caused by low frequency genetic variation. In this review, we outline the current pharmacogenomics knowledge of CYP3A activity and discuss potential future directions to improve our genetic knowledge and ability to explain CYP3A variability.
first_indexed 2024-12-12T10:53:43Z
format Article
id doaj.art-095cfae0737147a89d788acdd098a335
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-12T10:53:43Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-095cfae0737147a89d788acdd098a3352022-12-22T00:26:43ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-06-011310.3389/fphar.2022.912618912618Why We Need to Take a Closer Look at Genetic Contributions to CYP3A ActivityQinglian ZhaiMaaike van der LeeTeun van GelderJesse J. SwenCytochrome P450 3A (CYP3A) subfamily enzymes are involved in the metabolism of 40% of drugs in clinical use. Twin studies have indicated that 66% of the variability in CYP3A4 activity is hereditary. Yet, the complexity of the CYP3A locus and the lack of distinct drug metabolizer phenotypes has limited the identification and clinical application of CYP3A genetic variants compared to other Cytochrome P450 enzymes. In recent years evidence has emerged indicating that a substantial part of the missing heritability is caused by low frequency genetic variation. In this review, we outline the current pharmacogenomics knowledge of CYP3A activity and discuss potential future directions to improve our genetic knowledge and ability to explain CYP3A variability.https://www.frontiersin.org/articles/10.3389/fphar.2022.912618/fullCYP3A locusCYP3A4CYP3A5genetic variantsenzyme activitymissing heritability
spellingShingle Qinglian Zhai
Maaike van der Lee
Teun van Gelder
Jesse J. Swen
Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity
Frontiers in Pharmacology
CYP3A locus
CYP3A4
CYP3A5
genetic variants
enzyme activity
missing heritability
title Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity
title_full Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity
title_fullStr Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity
title_full_unstemmed Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity
title_short Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity
title_sort why we need to take a closer look at genetic contributions to cyp3a activity
topic CYP3A locus
CYP3A4
CYP3A5
genetic variants
enzyme activity
missing heritability
url https://www.frontiersin.org/articles/10.3389/fphar.2022.912618/full
work_keys_str_mv AT qinglianzhai whyweneedtotakeacloserlookatgeneticcontributionstocyp3aactivity
AT maaikevanderlee whyweneedtotakeacloserlookatgeneticcontributionstocyp3aactivity
AT teunvangelder whyweneedtotakeacloserlookatgeneticcontributionstocyp3aactivity
AT jessejswen whyweneedtotakeacloserlookatgeneticcontributionstocyp3aactivity